SpineEX (SPIX) Files ~$18M IPO

SpineEX files a $17.75 million IPO. The company plans to list on the NASDAQ under the symbol 'SPIX'.

ThinkEquity is the sole underweriter.

SpineEX is a medical device company focused on the design, development and marketing of products for spine disorders. They are developing an innovative, minimally invasive implant for spinal fusion surgeries, which they plan to package and sell with an array of complementary products if it is cleared or approved for marketing. The company is committed to continuously innovating, improving, and expanding our product line to accommodate any and all surgeons, methods, and areas of spinal surgery on a global scale.

More from S-1

You May Also Be Interested In

• Snow Rothschild Acquisition Corp. closes $200 million IPO
• EquipmentShare appoints two directors following IPO board transition
• Humacyte announces underwritten public offering of common stock